2m 2m 2m 2m 2m 2m 2m
ORUKA THERA (ORKA)
NASDAQ
$104.40+$1.97 (+1.93%)
Price as of Aug 24, 2026 7:30 PM EDT- $7.1BMarket Cap
- 605.86%1-Year Change
- BiotechnologyIndustry
ORUKA THERA (ORKA)
$104.40+$1.97 (+1.93%)
ORKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $102.42 | ||
Change | -$5.54 (-5.13%) | ||
Open | $106.75 | ||
High | $107.22 | ||
Low | $100.64 | ||
Previous Close | $107.96 | ||
Volume | 992,276 | ||
30-Day Average Volume | 813,930 | ||
1-Week Change | -9.09% | ||
1-Month Change | 11.13% | ||
1-Year Change | 605.86% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $1.1B | ||
Market Cap | $7.1B | ||
Enterprise Value | $6.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.2M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$41.2M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $861.6M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -167 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -196 | ||
PEG | 13 | ||
Price/Free Cash Flow | -216 | ||
Price/Operating Cash Flow | -216 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue